Increase of serum phosphatidylcholine hydroperoxide dependent on glycemic control in type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 56, Issue 1, 2002, Pages 19-25

  Nagashima, Tazuko ^a   Oikawa, Shinichi ^b   Hirayama, Yoshitake ^c   Tokita, Yoshihisa ^d   Sekikawa, Akihiro ^d   Ishigaki, Yasushi ^d   Yamada, Rie ^a   Miyazawa, Teruo ^c  

^a Tohoku Electron Indust Co Ltd   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemiluminescence high performance liquid chromatography; Diabetes mellitus; HbA1c; Phosphatidylcholine hydroperoxide

Indexed keywords

HEMOGLOBIN A1C; LIPID HYDROPEROXIDE; LIPID PEROXIDE; PHOSPHATIDYLCHOLINE HYDROPEROXIDE; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOANALYZER; CHEMOLUMINESCENCE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; REFERENCE VALUES; TRIGLYCERIDES;

EID: 0036177575     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(01)00353-9     Document Type: Article

References (35)

1. Free radicals and diabetes
2. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM
3. Elevation of plasma lipid peroxides in non-insulin-dependent diabetics with multiple lacunar infarcts
4. Hydroperoxides in plasma are reduced by intensified insulin treatment. A randomized controlled study of IDDM patients with microalbuminiuria
5. Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM
6. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM
7. 1c in the erythrocytes of diabetic patients
8. Lipid Peroxides and human diseases
9. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?
10. Age-related increase in plasma phosphatidylcholine concentrations in normal subjects and patients with hyperlipidemia
11. Role of oxidized low density lipoprotein in atherosclerosis
12. Determination of lipid hydroperoxides in low density lipoprotein from human plasma using high performance liquid chromatography with chemiluminescence detection
13. Determination of phospholipid hydroperoxides using luminol chemiluminescence-high-performance liquid chromatography
14. Tea catechin supplementation increases antioxidant capacity and prevents phospholipid hydroperoxidation in plasma of humans
15. Age-related change of phosphatidylcholine hydroperoxide and phosphatidylethanolamine hydroperoxide levels in normal human red blood cells
16. Separation of serum high density lipoprotein for cholesterol determination ultracentrifugation vs precipitation with sodium phosphotungstate and magnesium chloride
17. Rapid method of total lipid extraction and purification
18. Glycation and inactivation of human Cu-Zn-superoxide dismutase: identification of the in vitro glycated sites
19. In activation of Cu, Zn-superoxide dismutaase by in vitro glycation and in erythrocytes of diabetic patients
20. Effect of insulin on impaired antioxidant activities in aortic endothelial cell from diabetic rabbit
21. Glucose autoxidation and protein modification
22. 2-generation and lipid peroxidation during the oxidation of a glycated polypeptide, glycated polylysine, in the presence of iron-ADP
23. Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation
24. Glycosylated hemoglobin and fasting plasma glucose in the assessment of outpatient plycemic control in NIDDM
25. 1c levels in a diabetes detection program
26. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications
27. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
28. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-years study
29. Glycation of proteins as a source of superoxide
30. Oxidized lipoproteins found in patients with NIDDM stimulate radical-induced monocyte chemoattractant protein-1 mRNA expression in cultured human endothelial cells
31. IDL can stimulate atherogenic gene expression in cultured human vascular endothelial cells
32. Oxidation of high density lipoproteins I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by α-tocopherol
33. Protection of low density Lipoprotein against oxidative modification of high-density lipoprotein-associated paraoxonase
34. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein
35. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors